New Alzheimer’s Drug Announces Results
Last week, Eisai and Biogen announced significant results of its Phase 3 clinical trial of the drug lecanamab. Lecanamab is a monoclonal antibody that targets an early stage of the amyloid protein that forms plaques in the brains of people with Alzheimer’s disease. During an 18-month study in which 1795 participants received either drug or […]
Read More
Benefits of Clinical Trials: A Proactive Approach to Your Brain Health
What are Clinical Trials? Clinical trials are research studies in which treatments or diagnostic tools are tested for safety and efficacy. At The CRCNJ, we conduct clinical trials focused on memory loss, Alzheimer’s disease, Mild Cognitive Impairment, and dementia. What are the Benefits of Clinical Trials? Currently, 1 in 3 older adults die of Alzheimer’s […]
Read More
Diagnosing Alzheimer’s Disease: Access to Specialized Scans
Alzheimer’s disease research has made great advances in testing and imaging. Scientists are investigating a number of disease markers and diagnostic tests, which may accurately and reliably indicate whether a person has Alzheimer’s disease and how far it has progressed. Some of these tests use cutting-edge technology and are not widely available yet, so participation […]
Read More
Tips for Healthy Brain Aging
At some point in life, everyone will experience symptoms of brain aging. While your cognitive functioning may change as you get older, you can still take steps to keep your brain healthy as you age. Tips for Maintaining a Healthy Brain Exercise As well as helping you to sleep and feel better and more energized, […]
Read More
What Are Clinical Trials
What Are Clinical Trials? Clinical trials are research studies conducted to evaluate the safety and efficacy of a potential intervention or diagnostic tool. Each trial has specific criteria for participation, as well as a detailed protocol of assessments, timelines for participation, and drug administration (if applicable). Clinical intervention trials span an array of modalities or […]
Read More
Study Takes a New Approach to Alzheimer’s Disease by Focusing on the Gut
Scientists are exploring new types of medications to treat Alzheimer’s disease. The Green Memory study is novel, as it focuses on targeting the gut’s microbiome to determine if rebalancing certain bacteria with a naturally derived investigational medication would improve brain function and slow the progression of Alzheimer’s disease. This investigational medication has been approved for […]
Read More
